Healthcare

Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.

The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.

Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges

Data, Healthcare, Education … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.

Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.

Harnessing Context, Empathy & Expectations.

Four years after the WHO first declared a global health emergency we look at how views on everything from inflation to mental health have changed since 2020.

In five points, we break down how people around the world are dealing (or not) as the pandemic fades away, war grinds on and sticky inflation sticks around.

Le Temps launches the second thematic opinion survey to track Swiss concern and their impact on voting intentions.